Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 01, 2005 (Vol. 25, No. 17)

Science Articles, Science, Etc.

URL:www.firstscience.com/site/home/asp
  • Fun,informative reading
  • None
A quick view of this site reminded me of the delight I used to find as a kid whenever I saw a new issue of the Popular Science magazine. Like the magazine, the beat here is science in a very visible way. With catchy titles, such as “A Hitchhiker’s Guide to the Moon” and “Artificial Cells,” the site’s designers know a thing or two about catching attention. The excellent photographs don’t do harm either. Topics covered are all over the scientific landscape—from space exploration to biology to physics to volcanoes. There’s an article of the week, a poem of the week (nice touch, by the way), a book of the week, and pull down menus full of articles that will make anyone curious. One of the strongest sites of its type I’ve ever seen, FirstScience ought to be a bookmark in every scientific educator’s browser. Superb.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »